Tag: Wegovy
Wegovy approved to prevent heart problems or strokes in obese and overweight adults
A post-approval clinical study showed that Wegovy significantly reduced the risk of major adverse cardiovascular events by 20% compared to a placebo
The Medicines and...
Weight loss drug Semaglutide may increase risk of rare eye condition, study warns
Semaglutide is available as Ozempic for treating type 2 diabetes and as Wegovy for managing overweight and obesity
Amid the rapid rise in semaglutide usage,...
UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition
Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects
British pharmacies and slimming clinics are reducing prices for weight-loss...
Supply of GLP-1 RAs not expected to return to normal until the end of 2024, says DHSC
Clinicians have been instructed to avoid prescribing GLP-1 receptor agonists for off-label indications
The Department of Health and Social Care (DHSC) has issued an...
MHRA identifies two UK wholesalers selling Ozempic
There is no evidence of the falsified pens being dispensed to UK patients’
The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that Ozempic has...
‘Wegovy could be key to curing heart failure’
Novo Nordisk said its hugely popular drug Wegovy was shown to substantially ease heart failure in obese people, as the Danish drugmaker seeks to...